NPI: 1255623534 · GLEN BURNIE, MD 21061 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/05/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/05/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,021 | $19K |
| 2019 | 4,516 | $41K |
| 2020 | 840 | $14K |
| 2021 | 4,083 | $74K |
| 2022 | 3,971 | $76K |
| 2023 | 2,778 | $96K |
| 2024 | 2,252 | $86K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 7,891 | 922 | $327K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,128 | 515 | $44K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 180 | 116 | $26K |
| J1756 | Injection, iron sucrose, 1 mg | 1,488 | 413 | $5K |
| 83970 | 683 | 612 | $3K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 2,324 | 219 | $2K |
| A4657 | Syringe, with or without needle, each | 1,740 | 1,029 | $1K |
| 85048 | 897 | 813 | $0.00 | |
| 85041 | 896 | 813 | $0.00 | |
| 83540 | 374 | 336 | $0.00 | |
| 82108 | 14 | 14 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 124 | 108 | $0.00 |
| 83550 | 326 | 292 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 43 | 24 | $0.00 |
| 82728 | 340 | 309 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 13 | 13 | $0.00 |